- Report
- March 2024
- 185 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2022
- 301 Pages
Global
From €4030EUR$4,175USD£3,457GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- February 2022
- 89 Pages
Global
From €3200EUR$3,552USD£2,841GBP
The biopharmaceutical processing market is a subset of the biopharmaceutical industry, which focuses on the development and production of biopharmaceuticals. Biopharmaceuticals are drugs derived from living organisms, such as proteins, nucleic acids, and other biological molecules. The biopharmaceutical processing market is responsible for the production of these drugs, from the initial stages of research and development to the final stages of manufacturing and distribution. This market includes a variety of services, such as cell line development, process development, analytical testing, and manufacturing.
The biopharmaceutical processing market is highly competitive, with many companies offering a range of services. Some of the major players in the market include Lonza, Merck KGaA, Boehringer Ingelheim, Novasep, and Sartorius. Other companies in the market include Thermo Fisher Scientific, Fujifilm Diosynth Biotechnologies, and Catalent. Show Less Read more